tiprankstipranks
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
US Market
MIRA
MIRA Pharmaceuticals, Inc.
RESEARCH TOOLSreports
Want to see MIRA full AI Analyst Report?

MIRA Pharmaceuticals, Inc. (MIRA) Income Statement

288 Followers

MIRA Pharmaceuticals, Inc. Income Statement

Last quarter (Q4 2025), MIRA Pharmaceuticals, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, MIRA Pharmaceuticals, Inc.'s net income was $-5.98M. See MIRA Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 10.49M$ 8.02M$ 8.53M$ 7.05M$ 2.15M
Depreciation and Amortization
$ 0.00$ -2.00$ 0.00$ 7.05M$ 2.15M
EBITDA
$ -10.49M$ -8.02M$ -8.53M$ 0.00$ 0.00
Operating Income
$ -10.49M$ -8.02M$ -8.53M$ -7.05M$ -2.15M
Other Income/Expenses
$ 50.63K$ 165.67K$ -3.46M$ -10.25K$ -24.37K
Pretax Income
$ -10.44M$ -7.85M$ -11.98M$ -7.06M$ -2.18M
Net Income
$ -10.44M$ -7.85M$ -11.98M$ -7.06M$ -2.18M
Per Share Metrics
Basic EPS
$ -1.35$ -0.51$ -0.65$ -0.48$ -0.15
Diluted EPS
$ -1.35$ -0.51$ -0.65$ -0.48$ -0.15
Weighted Average Shares Outstanding
 23.69M 15.44M 18.57M 14.75M 14.75M
Weighted Average Shares Outstanding (Diluted)
 23.69M 15.44M 18.57M 14.75M 14.75M
Currency in USD

MIRA Pharmaceuticals, Inc. Earnings and Revenue History